Search bioRxiv⌕ Search

Biology subjects

Lounsbury, N. W.

Publications and source records attributed to Lounsbury, N. W..

5 recordsLinked to original sources

Predicting specificity of TCR-pMHC interactions using machine learning and biophysical models

Understanding the mechanism of T-cell activation and T-cell receptor (TCR) discrimination of MHC-presented epitope peptides (pMHCs) remains an open problem. Machine learning (ML)-based prediction of TCR specificity has gained considerable recent attention. However, the capacity of current models to generalize to peptides unseen during training is currently unknown. Here, we use a proprietary cancer-patient data set that profiles TCR binding to novel regions of peptide space to show that peptide generalization remains an unsolved problem. Specifically, we show that while ML methods have demonstrable utility in predicting TCR specificity for known peptides, they fail to generalize to novel peptides. We also show that physics-based methods utilizing classical energy functions outperform ML methods when predicting TCR binding to novel peptides but underperform them on known peptides. In light of these observations, we develop a new ML model that leverages general knowledge acquired by protein foundation models to achieve better or comparable performance than either ML or biophysical methods on both in- and out-of-distribution TCR-pMHC specificity prediction. We furthermore analyze model performance as a function of distance of TCR sequence specificity between the training and test sets to quantitatively characterize the generalization potential of any given TCR-pMHC model. Our analysis sheds light on the status of modeling TCR-pMHC interactions and suggests new paths forward for continued method development and data acquisition.

immunology↗

Pep2Vec: An Interpretable Model for Peptide-MHC Presentation Prediction and Contaminant Identification in Ligandome Datasets

As personalized cancer vaccines advance, precise modeling of antigen presentation by MHC class I and II is crucial. High-quality training data is essential for clinical models. Existing deep learning models focus on prediction performance but lack interpretability. We introduce Pep2Vec, a modular, transformer-based model trained on MHC I and II ligandome data, transforming input sequences into interpretable vectors. This approach integrates source protein features and elucidates the source of its performance gains, revealing regions that correlate with gene expression and protein-protein interactions. Pep2Vecs peptide latent space shows relationships between peptides of varying MHC class, allotype, lengths, and submotifs. This enables identifying four major contaminant types, constituting 5.0% of our data. Pep2Vec enhances MHC presentation prediction, achieving higher average precision on our presentation test set and immunogenicity datasets than existing models, and reducing contaminant-like peptide recommendations. Pep2Vec addresses a critical need for the development of more precise and effective applications of peptide MHC models, such as for cancer vaccines and antibody deimmunization.

immunology↗

HLApollo: A superior transformer model for pan-allelic peptide-MHC-I presentation prediction, with diverse negative coverage, deconvolution and protein language features.

Antigen presentation on MHC class I (MHC-I) is key to the adaptive immune response to cancerous cells. Computational prediction of peptide presentation by MHC-I has enabled individualized cancer immunotherapies. Here, we introduce HLApollo, a transformer-based approach with end-to-end modeling of MHC-I sequence, deconvolution, and flanking sequences. To achieve this, we develop a novel training strategy, negative set switching, which greatly reduces overfitting to falsely presumed negatives that are necessarily found in presentation datasets. HLApollo shows a meaningful improvement compared to recent MHC-I models on peptide presentation (20.19% average precision (AP)) and immunogenicity (4.1% AP). As expected, adding gene expression boosts the performance of HLApollo. More interestingly, we show that introduction of features from a protein language model, ESM 1b, remarkably recoups much of the benefits of gene expression in absence of true expression measurements. Finally, we demonstrate excellent pan-allelic generalization, and introduce a framework for estimating the expected accuracy of HLApollo for untrained alleles. This guides the use of HLApollo in a clinical setting, where rare alleles may be observed in some subjects, particularly for underrepresented minorities.

immunology↗

TRIAGE: A web-based iterative analysis platform integrating pathway and network databases optimizes hit selection from high- throughput assays.

Comprehensive and efficient gene hit selection from high throughput assays remains a critical bottleneck in realizing the potential of genome-scale studies in biology. Widely used methods such as setting of cutoffs, prioritizing pathway enrichments, or incorporating predicted network interactions offer divergent solutions yet are associated with critical analytical trade-offs, and are often combined in an ad hoc manner. The specific limitations of these individual approaches, the lack of a systematic way by which to integrate their rankings, and the inaccessibility of complex computational approaches to many researchers, has contributed to unexpected variability and limited overlap in the reported results from comparable genome-wide studies. Using a set of three highly studied genome-wide datasets for HIV host factors that have been broadly cited for their limited number of shared candidates, we characterize the specific complementary contributions of commonly used analysis approaches and find an optimal framework by which to integrate these methods. We describe Throughput Ranking by Iterative Analysis of Genomic Enrichment (TRIAGE), an integrated, iterative approach which uses pathway and network statistical methods and publicly available databases to optimize gene prioritization. TRIAGE is accessible as a secure, rapid, user-friendly web-based application (https://triage.niaid.nih.gov). O_FIG O_LINKSMALLFIG WIDTH=197 HEIGHT=200 SRC="FIGDIR/small/204917v2_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@7150f8org.highwire.dtl.DTLVardef@17af411org.highwire.dtl.DTLVardef@12d8f01org.highwire.dtl.DTLVardef@78c48_HPS_FORMAT_FIGEXP M_FIG Graphical Abstract C_FIG

bioinformatics↗

A sustained small increase in NOD1 expression promotes ligand-independent oncogenic activity

Small genetically-determined differences in transcription (eQTLs) are implicated in complex disease but the mechanisms by which small changes in gene expression impact complex disease are unknown. Here we show that a persistent small increase in expression of the innate sensor NOD1 precipitates large cancer-promoting changes in cell state. A ~1.2-1.4 fold increase in NOD1 protein concentration by loss of miR-15b/16 regulation sensitizes cells to ligand-induced inflammation, with an additional slight increase leading to ligand-independent NOD1 activation that is linked to poor prognosis in gastric cancer. Our data show that tight expression regulation of NOD1 prevents this sensor from exceeding a physiological switching checkpoint that promotes persistent inflammation and oncogene expression and reveal the impact of a single small quantitative change in cell state on cancer.\n\nOne Sentence SummaryA small change in NOD1 expression has a large cancer-promoting impact on cell state.

systems biology↗